Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Nursing home residents with respiratory syncytial virus (RSV) have high risk for illness, frequent hospitalization, and high mortality.

A panel for the Centers for Disease Control and Prevention voted to lower the recommended age for older adults to get their ...

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

Health experts say there are plenty of ways to halt the spread of respiratory illnesses as Michigan's weather grows colder.

The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...

While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...

Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.

With the arrival of colder temperatures, concerns are growing that a 'tripledemic' may be approaching. Health experts are ...

XEC has become the second most prevalent strain in the country, according to data released by the U.S. Centers for Disease Control and Prevention ( CDC ), representing more than 1 in 10 cases. But ...

The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two ...